Preservative-free treprostinil formulations and methods and devices for use with same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10632129
APP PUB NO 20170340647A1
SERIAL NO

15528452

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides for a unit dosage form of treprostinil at a dosage of between 0.1 mg/mL and 25 mg/mL in a sterile fluid composition formulated for subcutaneous or intravenous injection, which composition does not comprise an antimicrobial preservative, and methods of reducing irritation, inflammation or a combination thereof at a site of subcutaneous or intravenous infusion of treprostinil in a subject in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNITED THERAPEUTICS CORPORATION1000 SPRING STREET SILVER SPRING MD 20910

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Noymer, Peter Los Gatos, US 11 55
Rigby, Jonathan San Ramon, US 4 34
Zwolinski, Robert Napa, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 28, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00